153 related articles for article (PubMed ID: 16025661)
1. [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
Pavie J; Porcher R; Fournier S; André F; Tournoux C; Palmer P; Rabian C; Jean-Michel M
Presse Med; 2005 Jun; 34(10 Suppl):1S8-13. PubMed ID: 16025661
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.
Pialoux G; Quercia RP; Gahery H; Daniel N; Slama L; Girard PM; Bonnard P; Rozenbaum W; Schneider V; Salmon D; Guillet JG
Clin Vaccine Immunol; 2008 Mar; 15(3):562-8. PubMed ID: 18184824
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.
Ormaasen V; Bruun JN; Sandvik L; Holberg-Petersen M; Gaarder PI
Scand J Infect Dis; 2003; 35(6-7):383-8. PubMed ID: 12953949
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
6. Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.
Tomasoni LR; Patroni A; Torti C; Paraninfo G; Gargiulo F; Quiros-Roldan E; Uccelli MC; Airò P; Tinelli C; Carosi G; Castelli F;
HIV Clin Trials; 2003; 4(5):311-23. PubMed ID: 14583847
[TBL] [Abstract][Full Text] [Related]
7. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
[TBL] [Abstract][Full Text] [Related]
8. [Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
Rey D; Schmitt MP; Hess-Kempf G; Krantz V; Partisani M; Bernard-Henry C; Lang JM
Pathol Biol (Paris); 2001 Sep; 49(7):559-66. PubMed ID: 11642019
[TBL] [Abstract][Full Text] [Related]
9. Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.
Deng SC; Chen MY; Hsieh SM; Sheng WH; Hsiao CF; Hung CC; Chang SC
J Microbiol Immunol Infect; 2003 Mar; 36(1):10-4. PubMed ID: 12741726
[TBL] [Abstract][Full Text] [Related]
10. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN
AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823
[TBL] [Abstract][Full Text] [Related]
11. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
12. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
[TBL] [Abstract][Full Text] [Related]
13. Response to highly active antiretroviral therapy according to duration of HIV infection.
Pezzotti P; Pappagallo M; Phillips AN; Boros S; Valdarchi C; Sinicco A; Zaccarelli M; Rezza G;
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):473-9. PubMed ID: 11391168
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
15. The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: a case-control study.
Kim KH; Yi J; Lee SH
Korean J Intern Med; 2015 Sep; 30(5):705-13. PubMed ID: 26354065
[TBL] [Abstract][Full Text] [Related]
16. Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART.
Re MC; Ramazzotti E; Manfredi R; Furlini G; Vignoli M; Maldini C; Borderi M; La Placa M
J Clin Virol; 2000 Jun; 17(1):5-11. PubMed ID: 10814933
[TBL] [Abstract][Full Text] [Related]
17. Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
Kousignian I; Abgrall S; Duval X; Descamps D; Matheron S; Costagliola D;
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):50-7. PubMed ID: 14501793
[TBL] [Abstract][Full Text] [Related]
18. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
Orenstein JM; Bhat N; Yoder C; Fox C; Polis MA; Metcalf JA; Kovacs JA; Falloon J; Walker RE; Masur H; Lane HC; Davey RT
AIDS; 2000 Aug; 14(12):1709-15. PubMed ID: 10985306
[TBL] [Abstract][Full Text] [Related]
19. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.
Davey RT; Bhat N; Yoder C; Chun TW; Metcalf JA; Dewar R; Natarajan V; Lempicki RA; Adelsberger JW; Miller KD; Kovacs JA; Polis MA; Walker RE; Falloon J; Masur H; Gee D; Baseler M; Dimitrov DS; Fauci AS; Lane HC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15109-14. PubMed ID: 10611346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
